Moreover, the results obtained from UALCAN indicated that TBK1 expression was significantly increased in bladder urothelial carcinoma (BLCA), breast invasive carcinoma (BRCA), cholangiocarcinoma (CHOL), colon adenocarcinoma (COAD), esophageal carcinoma (ESCA), head and neck squamous cell carcinoma (HNSC), kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), LIHC, lung adenocarcinoma (LUAD), lung squamous cell carcinoma(LUSC), and stomach adenocarcinoma (STAD) (Figure 1B). The gene discussed is TBK1; the disease is cholangiocarcinoma.